Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.

By W. Eiermann, S. Paepke, J. Appfelstaedt, A. Llombart-Cussac, J. Eremin, J. Vinholes, L. Mauriac, M. Ellis, M. Lassus, H. Chaudri-Ross and 3 more. Annals of Oncology, 2001

725 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics

View Paper: https://www.semanticscholar.org/paper/e2b30ec2a95da671b8be5ed762e289d34e3594df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Penault-Llorca
2. E. Senkus
3. F. Cardoso
4. P. Poortmans
5. S. Kyriakides
6. S. Ohno
7. S. Zackrisson
8. E. Rutgers

Citations in the corpus

• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “If such drugs cannot be replaced, a switch to alternative treatment, i.e. AIs, should be considered [IV, B] [116, 117].”